Yellow (577 nm) micropulse laser versus half-dose verteporfin photodynamic therapy in eyes with chronic central serous chorioretinopathy: Results of the Pan-American Collaborative Retina Study (PACORES) Group

Purpose To compare the functional and anatomical outcomes of eyes with chronic central serous chorioretinopathy treated with yellow micropulse (MP) laser versus half-dose verteporfin photodynamic therapy (PDT). Methods This is a multicentre, retrospective comparative study of 92 eyes treated with ye...

Full description

Autores:

Tipo de recurso:

Fecha de publicación:

2018

Institución:

Universidad del Rosario

Repositorio:

Repositorio EdocUR - U. Rosario

Idioma:

eng

OAI Identifier:

oai:repository.urosario.edu.co:10336/23613

Acceso en línea:

https://doi.org/10.1136/bjophthalmol-2017-311291
https://repository.urosario.edu.co/handle/10336/23613

Palabra clave:

Bevacizumab
Verteporfin
Indocyanine green
Photosensitizing agent
Verteporfin
Adult
Article
Best corrected visual acuity
Central serous retinopathy
Comparative study
Controlled study
Disease duration
Female
Follow up
Human
Intermethod comparison
Laser surgery
Major clinical study
Male
Middle aged
Multicenter study (topic)
Photodynamic therapy
Priority journal
Retrospective study
Subretinal neovascularization
Treatment outcome
Yellow micropulse laser
Central serous retinopathy
Chronic disease
Clinical trial
Fluorescence angiography
Low level laser therapy
Multicenter study
Optical coherence tomography
Pathophysiology
Photochemotherapy
Physiology
Procedures
Visual acuity
Adult
Central serous chorioretinopathy
Chronic disease
Female
Fluorescein angiography
Follow-up studies
Humans
Indocyanine green
Laser therapy
Male
Middle aged
Photochemotherapy
Photosensitizing agents
Retrospective studies
Treatment outcome
Verteporfin
Visual acuity
Macula
Retina
Treatment lasers
optical coherence
Tomography

Rights

License

Abierto (Texto Completo)